Nam Jiho, Woo Hyunmin, Yang Jihye, Kim Seok Jung, Lee Kwang Pyo, Yu Ji Hoon, Park Tae Joo, Eyun Seong-Il, Yang Siyoung
Department of Biological Science, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Department of Life Science, Chung-Ang University, Seoul, 06974, Republic of Korea.
Adv Sci (Weinh). 2025 Apr;12(16):e2404311. doi: 10.1002/advs.202404311. Epub 2025 Mar 5.
Susceptibility to cartilage degeneration increases in an age-dependent manner and older cartilage exhibits increased catabolic factor expression leading to osteoarthritis (OA). While inhibition of cellular senescence can prevent age-related diseases, the understanding of the regulators governing cartilage senescence and the potential for senolytic intervention remains limited. Here, in vitro and in vivo results are reported, demonstrating for the first time that the transcriptional regulator, ZMIZ1, is upregulated in aged and OA cartilage, and that it acts through GATA4 to accelerate chondrocyte senescence and trigger cartilage deterioration. Furthermore, it is shown that K-7174 interferes with the ZMIZ1-GATA4 interaction and effectively hampers cartilage senescence and OA. It is proposed that inhibition of the ZMIZ1-GATA4 axis could be a valuable strategy for eliminating senescent chondrocytes and impeding OA development and that the relevant inhibitor, K-7174, could potentially be developed as a senolytic drug for managing cartilage senescence and age-related degeneration.
软骨退变的易感性以年龄依赖性方式增加,并且老年软骨表现出分解代谢因子表达增加,从而导致骨关节炎(OA)。虽然抑制细胞衰老可以预防与年龄相关的疾病,但对控制软骨衰老的调节因子以及衰老细胞溶解干预潜力的了解仍然有限。在此,报告了体外和体内结果,首次证明转录调节因子ZMIZ1在衰老和OA软骨中上调,并且它通过GATA4发挥作用以加速软骨细胞衰老并引发软骨退变。此外,研究表明K-7174干扰ZMIZ1-GATA4相互作用并有效阻碍软骨衰老和OA。有人提出,抑制ZMIZ1-GATA4轴可能是消除衰老软骨细胞和阻碍OA发展的有价值策略,并且相关抑制剂K-7174有可能被开发为用于管理软骨衰老和与年龄相关退变的衰老细胞溶解药物。